NCT03633955View on ClinicalTrials.gov

Pilot Imaging Study of Leukemia

PHASE1RecruitingINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

January 19, 2023

Primary Completion Date

March 31, 2026

Study Completion Date

April 30, 2028

Conditions
Acute Lymphocytic LeukemiaAcute Myeloid LeukemiaAmbiguous Lineage Leukemia or LymphomaMyeloma
Interventions
DRUG

FLT

F18 labeled thymidine PET/CT scans will be performed before and after patient receives therapies.

Trial Locations (3)

20010

WITHDRAWN

Children's National Health System, Washington D.C.

30322

NOT_YET_RECRUITING

Emory University, Atlanta

73117

RECRUITING

University of Oklahoma Health Sciences Center, Oklahoma City

All Listed Sponsors
collaborator

Emory University

OTHER

lead

University of Oklahoma

OTHER